Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
329.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 14.00 (4.348%)
Market Cap: £41.75m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Director Dealing

7 Jun 2011 07:00

RNS Number : 9572H
BrainJuicer Group PLC
07 June 2011
 



 

 

Press Release

 7 June 2011

 

 

BrainJuicer Group PLC

 

("BrainJuicer" or "the Company")

 

Director Dealing

 

As previously announced on the 21 July 2010, John Kearon, the Company's Chief Executive Officer, borrowed £650,000 from third party lenders (the "Lenders") ("Loan"). As part of the loan agreement, Mr Kearon had the right to repay the Loan by converting it into 400,000 ordinary shares, subject to the closing mid market price of BrainJuicer ordinary shares being in excess of 255 pence for twenty (20) consecutive trading days.

 

Mr Kearon has exercised his right for the conversion of the Loan and as a result transferred 400,000 ordinary shares to the Lenders on 2 June 2011. This represents 3.2 per cent. of the Company's issued share capital with voting rights.

 

In addition to the above, Mr Kearon has today transferred a total of 249,062 ordinary shares representing 2.0 per cent. of the Company's issued share capital with voting rights to Sarah Kearon.

 

Following the above transactions, John Kearon's direct holding is provided below:

 

Number of ordinary shares held prior to

Ordinary shares transferred to Sarah Kearon

Ordinary shares transferred to the Lenders

Total number of ordinary shares held post transactions

% of total issued share capital with voting rights

4,510,164

249,062

400,000

3,861,102

31.0%

 

John Kearon's beneficial holding, including 249,062 transferred to Sarah Kearon represents 33.0 per cent. of the total issued share capital with voting rights.

 

- Ends -

 

For further information, please contact:

BrainJuicer plc

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Genuity Limited

Mark Williams / Henry Fitzgerald-O'Connor

Tel: +44 (0) 20 7050 6500

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSAFWMFFSEDM
Date   Source Headline
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSQuarterly Trading Update
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
30th Jun 20224:15 pmRNSHolding(s) in Company
30th Jun 20229:30 amRNSHolding(s) in Company
27th Jun 20223:00 pmRNSDirectorate Change
22nd Jun 20227:00 amRNSDistribution policy
6th Jun 20227:00 amRNSHolding(s) in Company
26th May 20221:15 pmRNSDirectorate Change
13th May 202212:15 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSTrading Update
1st Apr 20222:00 pmRNSCompletion of Share Buyback Programme
25th Mar 20225:21 pmRNSTransaction in Own Shares
23rd Mar 20223:30 pmRNSTransaction in Own Shares
22nd Mar 20225:32 pmRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSUpdate re Stefan Barden
11th Mar 20226:00 pmRNSTransaction in Own Shares
11th Mar 20223:30 pmRNSHolding(s) in Company
4th Mar 20226:25 pmRNSTransaction in Own Shares
4th Mar 202210:15 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20224:15 pmRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTrading Update
21st Feb 20223:15 pmRNSTransaction in Own Shares
18th Feb 20225:31 pmRNSTransaction in Own Shares
16th Feb 20225:30 pmRNSTransaction in Own Shares
15th Feb 202210:15 amRNSTransaction in Own Shares
14th Feb 20225:02 pmRNSTransaction in Own Shares
11th Feb 20225:15 pmRNSTransaction in Own Shares
9th Feb 20223:45 pmRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTrading Update
4th Feb 202211:45 amRNSHolding(s) in Company
24th Jan 20225:50 pmRNSTransaction in Own Shares
21st Jan 20225:15 pmRNSTransaction in Own Shares
20th Jan 20225:15 pmRNSTransaction in Own Shares
12th Jan 202212:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.